Renaissance Technologies LLC Sells 123,900 Shares of Strata Critical Medical $SRTA

Renaissance Technologies LLC decreased its position in shares of Strata Critical Medical (NASDAQ:SRTA) by 20.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 474,886 shares of the company’s stock after selling 123,900 shares during the quarter. Renaissance Technologies LLC owned approximately 0.55% of Strata Critical Medical worth $1,985,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Seelaus Asset Management LLC increased its holdings in Strata Critical Medical by 32.7% in the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock worth $102,000 after purchasing an additional 6,000 shares in the last quarter. Granite Investment Partners LLC boosted its stake in shares of Strata Critical Medical by 77.0% during the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after purchasing an additional 7,911 shares in the last quarter. Principal Financial Group Inc. acquired a new stake in shares of Strata Critical Medical during the first quarter valued at about $537,000. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Strata Critical Medical by 11.9% during the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock worth $6,759,000 after purchasing an additional 172,154 shares during the last quarter. Institutional investors own 47.36% of the company’s stock.

Insider Activity at Strata Critical Medical

In related news, CEO Melissa M. Tomkiel sold 29,730 shares of the firm’s stock in a transaction on Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $174,515.10. Following the completion of the transaction, the chief executive officer directly owned 1,892,774 shares of the company’s stock, valued at $11,110,583.38. This trade represents a 1.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO William A. Heyburn sold 31,671 shares of Strata Critical Medical stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total value of $185,908.77. Following the transaction, the chief executive officer directly owned 1,548,997 shares in the company, valued at $9,092,612.39. The trade was a 2.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 116,931 shares of company stock worth $687,184 over the last three months. Company insiders own 15.50% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Strata Critical Medical from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $8.00.

Strata Critical Medical Trading Up 1.5%

Shares of NASDAQ:SRTA opened at $6.03 on Wednesday. Strata Critical Medical has a 52 week low of $3.85 and a 52 week high of $6.50. The firm has a market capitalization of $521.78 million, a price-to-earnings ratio of -75.38 and a beta of 2.25. The business’s fifty day simple moving average is $5.45.

Strata Critical Medical Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.